Invitrogen teams with Inter'l Regulome Consortium

Guest Contributor
July 7, 2008

The International Regulome Consortium (IRC) has signed a letter of intent with Invitrogen Corp to develop tools for stem cell research. IRC will use Invitrogen's expertise in stem cell biology to accelerate its research into determining how stem cells give rise to specialized cells such as neurons. IRC is a third generation, international genomics project involving 58 researchers from 34 institutions in 12 countries. It is headquartered in Canada under the leadership of Dr Michael Rudnicki, a senior scientist at the Ottawa Health Research Institute….

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.